Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $895.82 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $324.39 | 17 | $0 (2022) |
| Galderma Laboratories, L.P. | $179.59 | 9 | $0 (2024) |
| PFIZER INC. | $102.11 | 2 | $0 (2023) |
| ABBVIE INC. | $75.47 | 4 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $69.06 | 4 | $0 (2020) |
| Celgene Corporation | $42.64 | 2 | $0 (2018) |
| Merz North America, Inc. | $31.12 | 1 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $26.60 | 1 | $0 (2023) |
| Incyte Corporation | $24.11 | 1 | $0 (2024) |
| EPI Health, LLC | $19.05 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.14 | 4 | ABBVIE INC. ($37.67) |
| 2023 | $145.71 | 4 | PFIZER INC. ($81.31) |
| 2022 | $145.84 | 6 | Allergan, Inc. ($92.31) |
| 2021 | $102.76 | 5 | Allergan, Inc. ($56.81) |
| 2020 | $76.50 | 4 | Allergan, Inc. ($22.56) |
| 2019 | $95.07 | 6 | Allergan Inc. ($61.27) |
| 2018 | $104.78 | 6 | Celgene Corporation ($42.64) |
| 2017 | $139.02 | 8 | Allergan Inc. ($91.44) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $24.36 | General |
| 08/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.29 | General |
| 02/29/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.38 | General |
| 02/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.11 | General |
| Category: Dermatology | ||||||
| 10/19/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 09/23/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $81.31 | General |
| Category: Inflammation & Immunology | ||||||
| 06/15/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $21.85 | General |
| 04/27/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Dermatology | ||||||
| 11/10/2022 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.41 | General |
| 10/25/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $20.74 | General |
| 08/05/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $22.23 | General |
| 08/04/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $31.12 | General |
| 07/21/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $27.49 | General |
| 01/21/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $21.85 | General |
| 10/28/2021 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $23.38 | General |
| 10/14/2021 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $13.47 | General |
| 09/30/2021 | Galderma Laboratories, L.P. | ORACEA (Drug), AKLIEF | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: ROSACEA | ||||||
| 06/10/2021 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.66 | General |
| 02/18/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/20/2020 | EPI Health, LLC | Sitavig (Drug), Cloderm, Minolira 105mg | Food and Beverage | Cash or cash equivalent | $19.05 | General |
| Category: Dermatology | ||||||
| 06/24/2020 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 03/19/2020 | Ortho Dermatologics, a division of Bausch Health US, LLC | ALTRENO (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: DERMATOLOGY | ||||||
| 02/14/2020 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $22.56 | General |
| 11/12/2019 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $16.98 | General |
| 10/25/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), BRYHALI | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: PODIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 211 | 290 | $50,067 | $18,357 |
| 2022 | 6 | 137 | 176 | $34,847 | $13,224 |
| 2021 | 5 | 125 | 169 | $32,934 | $13,835 |
| 2020 | 5 | 101 | 126 | $24,878 | $9,048 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 47 | $11,750 | $4,692 | 39.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 38 | 48 | $9,360 | $3,657 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 45 | $7,875 | $3,166 | 40.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 53 | $6,625 | $2,514 | 38.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 15 | 19 | $3,857 | $1,801 | 46.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 27 | 35 | $6,300 | $1,465 | 23.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,525 | $871.20 | 24.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 11 | 31 | $775.00 | $190.51 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 50 | $12,500 | $4,841 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 38 | $6,650 | $2,534 | 38.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 24 | 31 | $6,045 | $2,381 | 39.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 16 | 19 | $3,857 | $1,840 | 47.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 15 | 19 | $3,420 | $844.23 | 24.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 19 | $2,375 | $784.04 | 33.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 72 | $12,600 | $5,567 | 44.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 32 | 38 | $7,410 | $3,121 | 42.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 27 | $6,750 | $2,663 | 39.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 16 | 18 | $3,654 | $1,909 | 52.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 13 | 14 | $2,520 | $575.32 | 22.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 46 | $8,050 | $2,785 | 34.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 20 | 26 | $5,070 | $2,072 | 40.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 20 | $5,000 | $1,590 | 31.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 13 | 16 | $3,248 | $1,480 | 45.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 14 | 18 | $3,510 | $1,120 | 31.9% |
About Dr. Peter Kopelson, MD
Dr. Peter Kopelson, MD is a Dermatology healthcare provider based in Beverly Hills, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053300806.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Kopelson, MD has received a total of $895.82 in payments from pharmaceutical and medical device companies, with $86.14 received in 2024. These payments were reported across 43 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($895.82).
As a Medicare-enrolled provider, Kopelson has provided services to 574 Medicare beneficiaries, totaling 761 services with total Medicare billing of $54,464. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Beverly Hills, CA
- Active Since 10/14/2005
- Last Updated 08/20/2014
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1053300806
Products in Payments
- CIBINQO (Drug) $81.31
- KYBELLA (Biological) $32.78
- Winlevi (Drug) $26.60
- OPZELURA (Drug) $24.11
- ORACEA (Drug) $23.29
- EUCRISA (Drug) $20.80
- BOTOX (Biological) $19.96
- HYLATOPIC EMOLLIENT (Drug) $19.82
- Sitavig (Drug) $19.05
- ALTRENO (Drug) $18.94
- RETIN-A-MICRO (Drug) $16.32
- BOTOX COSMETIC (Biological) $14.43
- JUBLIA (Drug) $13.98
- Ameluz (Drug) $1.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Beverly Hills
Dr. Paul Wallace, Md, MD
Dermatology — Payments: $668,849
Jacquiline Hakim, D.o, D.O
Dermatology — Payments: $103,641
Haleh Bakshandeh, Md, MD
Dermatology — Payments: $90,782
Dr. Howard Liu, M.d, M.D
Dermatology — Payments: $76,959
Dr. Monika Kiripolsky, M.d, M.D
Dermatology — Payments: $23,596
Kenneth Washenik, M.d, M.D
Dermatology — Payments: $20,007